Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-09-19

Clinical Trial Update: Asprosin in Breast Cancer

View source ↗

Summary

A clinical trial is investigating Asprosin for breast cancer. The study is currently not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Asprosin (Asprosin)

Snippet

Sponsor: Marina Hanna Thabet Ghobrial | Conditions: Breast Cancer | Status: NOT_YET_RECRUITING